Bevacizumab as a treatment option for choroidal neovascularisation due to large optic nerve drusen in a 14-year-old girl
Purpose: To report the effects of a single intravitreous injection of bevacizumab for the treatment of secondary choroideal neovascularisation due to large optic disc drusen.Methods: A 14-year-old female patient with painless loss of vision iye presented with unusually large optic disc drusen and jy...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
German Medical Science GMS Publishing House
2020-08-01
|
| Series: | GMS Ophthalmology Cases |
| Subjects: | |
| Online Access: | http://www.egms.de/static/en/journals/oc/2020-10/oc000160.shtml |
| _version_ | 1818524716599607296 |
|---|---|
| author | Steinhorst, Nils Alexander Spitzer, Martin Skevas, Christos |
| author_facet | Steinhorst, Nils Alexander Spitzer, Martin Skevas, Christos |
| author_sort | Steinhorst, Nils Alexander |
| collection | DOAJ |
| description | Purpose: To report the effects of a single intravitreous injection of bevacizumab for the treatment of secondary choroideal neovascularisation due to large optic disc drusen.Methods: A 14-year-old female patient with painless loss of vision iye presented with unusually large optic disc drusen and jy choroidal neovascularisation with subretinal hemorrhaghe was treated with a single intravitreous injection of bevacizumab.Results: Visual acuity increased from 20/100 to 20/25 within 4 weeks after injection and remained at this level during the 12-month follow-up period.Conclusions: Bevacizumab is a possible primary treatment option for secondary choroidal neovascularisation due to large optic disc drusen in children as an alternative to other more invasive or complex procedures. |
| first_indexed | 2024-12-11T06:00:34Z |
| format | Article |
| id | doaj.art-f7914a6b0afd475b8aea6af332488950 |
| institution | Directory Open Access Journal |
| issn | 2193-1496 |
| language | English |
| last_indexed | 2024-12-11T06:00:34Z |
| publishDate | 2020-08-01 |
| publisher | German Medical Science GMS Publishing House |
| record_format | Article |
| series | GMS Ophthalmology Cases |
| spelling | doaj.art-f7914a6b0afd475b8aea6af3324889502022-12-22T01:18:30ZengGerman Medical Science GMS Publishing HouseGMS Ophthalmology Cases2193-14962020-08-0110Doc3310.3205/oc000160Bevacizumab as a treatment option for choroidal neovascularisation due to large optic nerve drusen in a 14-year-old girlSteinhorst, Nils Alexander0Spitzer, Martin1Skevas, Christos2Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyDepartment of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyDepartment of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyPurpose: To report the effects of a single intravitreous injection of bevacizumab for the treatment of secondary choroideal neovascularisation due to large optic disc drusen.Methods: A 14-year-old female patient with painless loss of vision iye presented with unusually large optic disc drusen and jy choroidal neovascularisation with subretinal hemorrhaghe was treated with a single intravitreous injection of bevacizumab.Results: Visual acuity increased from 20/100 to 20/25 within 4 weeks after injection and remained at this level during the 12-month follow-up period.Conclusions: Bevacizumab is a possible primary treatment option for secondary choroidal neovascularisation due to large optic disc drusen in children as an alternative to other more invasive or complex procedures.http://www.egms.de/static/en/journals/oc/2020-10/oc000160.shtmljuvenileoptic disc drusenchoroidal neovascularisationcystoid edemabevacizumab |
| spellingShingle | Steinhorst, Nils Alexander Spitzer, Martin Skevas, Christos Bevacizumab as a treatment option for choroidal neovascularisation due to large optic nerve drusen in a 14-year-old girl GMS Ophthalmology Cases juvenile optic disc drusen choroidal neovascularisation cystoid edema bevacizumab |
| title | Bevacizumab as a treatment option for choroidal neovascularisation due to large optic nerve drusen in a 14-year-old girl |
| title_full | Bevacizumab as a treatment option for choroidal neovascularisation due to large optic nerve drusen in a 14-year-old girl |
| title_fullStr | Bevacizumab as a treatment option for choroidal neovascularisation due to large optic nerve drusen in a 14-year-old girl |
| title_full_unstemmed | Bevacizumab as a treatment option for choroidal neovascularisation due to large optic nerve drusen in a 14-year-old girl |
| title_short | Bevacizumab as a treatment option for choroidal neovascularisation due to large optic nerve drusen in a 14-year-old girl |
| title_sort | bevacizumab as a treatment option for choroidal neovascularisation due to large optic nerve drusen in a 14 year old girl |
| topic | juvenile optic disc drusen choroidal neovascularisation cystoid edema bevacizumab |
| url | http://www.egms.de/static/en/journals/oc/2020-10/oc000160.shtml |
| work_keys_str_mv | AT steinhorstnilsalexander bevacizumabasatreatmentoptionforchoroidalneovascularisationduetolargeopticnervedrusenina14yearoldgirl AT spitzermartin bevacizumabasatreatmentoptionforchoroidalneovascularisationduetolargeopticnervedrusenina14yearoldgirl AT skevaschristos bevacizumabasatreatmentoptionforchoroidalneovascularisationduetolargeopticnervedrusenina14yearoldgirl |